TMPRSS2 (P5H9-A3) Antibody sc-101847 from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

TMPRSS2 (P5H9-A3) Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
TMPRSS2 (P5H9-A3) Antibody

The TMPRSS2 (P5H9-A3) Antibody from Santa Cruz Biotechnology, Inc. is a Mouse Monoclonal antibody to TMPRSS2. This antibody recognizes Homo Sapiens, and Human antigen. The TMPRSS2 (P5H9-A3) Antibody has been shown to work in the following applications: Immunofluorescence, Immunohistochemistry - fixed, and Western Blot.

Description

TMPRSS2 (P5H9-A3)

Product Specs
ItemTMPRSS2 (P5H9-A3) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-101847
Antibody TypePrimary Antibodies
NCBI Gene AliasesPRSS10
Quantity200 µg/ml
CloneP5H9-A3
FormatPurified
ClonalityMonoclonal
Reactivityhuman
ApplicationsWB, IF, IHC(P)
Conjugate/TagUnconjugated
Hostmouse
NCBI Full Gene Nametransmembrane serine protease 2
TargetTMPRSS2
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human SpermCellsAugust 24, 2022Luddi A, Luongo FP, Dragoni F, Fiaschi L, Vicenti I, Lupetti P, Gentile M, Paccagnini E, Haxhiu A, Ponchia R, et al.

(2) Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassaysActa Pharmacologica SinicaJanuary 1, 2022Jin-ping Pang et al.Signaling Technology Cat# 5153, RRID:AB 10691711) and mouse anti-TMPRSS2 (Santa Cruz Biotechnology Cat# sc-101847, RRID:AB 2205599), along with monoclonal anti-GAPDH (Cell Signaling Technology Cat# 5174, RRID:AB 10622025)

(3) No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 InfectionFrontiers in cellular and infection microbiologyJanuary 1, 2021García-Nicolás O, V''kovski P, Zettl F, Zimmer G, Thiel V, Summerfield A.

Be the First to Write a Review!